|
|
|||||||||||
Brownhill Centre, Swindon Road, Cheltenham GL51 9EZ
Queen Elizabeth Psychiatric Hospital, Birmingham
Wotton Lawn, Gloucester
Queen Elizabeth Psychiatric Hospital, Birmingham
|
|
Abstract |
|---|
|
|
|---|
A prospective study comparing initial electroconvulsive therapy treatment doses determined by empirical dose titration with estimates derived from two simple dose prediction methods and a fixed-dose regimen (275 mC).
RESULTS
Thirty-three patients had seizure thresholds between 25 mC and 403 mC. The dose titration method led to a mean initial treatment dose of 195 mC that was intermediate between those predicted by the age method (275 mC) and the half-age method (137 mC). Estimates were within acceptable limits in 33% of cases for the age method, 64% for the half-age method and 40% for the fixed-dose method.
CLINICAL IMPLICATIONS
Either dose prediction or dose titration methods may be more appropriate in different clinical situations. The half-age method appears to be a more accurate predictor of optimum initial treatment dose.
|
|
Introduction |
|---|
|
|
|---|
Determining the stimulus dose may be important for several reasons. Sub-convulsive stimuli are clearly ineffective but marginally supra-threshold stimuli, despite producing seizures of apparently adequate length, are very poor at relieving depressive symptoms. The use of moderately supra-threshold stimuli significantly improves the efficacy of unilateral ECT and leads to a faster response to bilateral ECT. Increasing stimulus magnitude is also associated with a worsening of cognitive side-effects. Both efficacy and cognitive side-effects appear to be more closely related to the degree to which the stimulus exceeds the patient's seizure threshold rather than to the absolute magnitude of the electrical dose (Sackeim et al, 1993). Utilising a MECTA SR1 machine, Enns & Karvelas (1995) found empirical titration to be a more consistent method of selecting an electrical dose than predictive methods. This study aimed to compare initial treatment dose determined by empirical dose titration with two simple dose prediction methods and a fixed-dose regimen utilising a Thymatron DGX constant-current machine.
|
|
The study |
|---|
|
|
|---|
No pre-medication was used and patients were anaesthetised with methohexitone (0.75 mg/kg) and paralysed with suxamethonium (0.5 mg/kg), the doses being adjusted according to clinical need. Atropine was not given routinely. Patients were hyperoxygenated prior to the initial stimulation. The research method for dose titration was a modification of that described by Lock in the ECT Handbook (Royal College of Psychiatrists, 1995). It was developed to accurately determine seizure threshold while keeping anaesthesia brief and maximising the chance of a patient having a therapeutic seizure during the first treatment session. Dose increments between different levels are initially small, increasing progressively in magnitude to cover the full range of the machine taking into account the proportionate relationship between stimulus dose and clinical outcome.
Starting levels for subjects (Table 1) were as follows: female unilateral (Level 1), male unilateral and female bilateral (Level 2), male bilateral (Level 3). Doses were increased by one level if patients were aged over 65 years or taking anticonvulsant medication. Seizure threshold was defined as the minimum electrical dose required to produce a generalised seizure lasting more than 25 seconds as measured by a single channel electroencephalogram recording via a left fronto-mastoid electrode placement. Following the first stimulation the electrical dose was increased by one level if there was no seizure (similarly for inadequate seizures). If there was no seizure on the second application the stimulus was increased by three levels for the final application. If the patient failed to have a seizure at the first treatment session, the titration process was continued at the next starting one level higher. If the patient previously had a seizure only on the third application, then the dose titration process was continued starting two levels lower. The dose titration process was similarly continued for a third ECT session if necessary. Subsequently initial treatment doses were set at seizure threshold plus one level for bilateral ECT and seizure threshold plus two levels for unilateral ECT.
|
Two dose prediction methods were compared with the research protocol. The age method described in the Thymatron manual (Swartz & Abrams, 1989) involves setting the stimulus control dial (percentage energy) to the patient's age. The second half-age method is similar but with the dose set to one half of the patient's age (Petrides & Fink, 1996). In a previous audit (Bentham et al, 1998) 97% of stimuli were given with a dose of 275 mC (50% above mean seizure threshold), comparisons were also made with this fixed-dose regimen.
|
|
Findings |
|---|
|
|
|---|
|
|
|
Discussion |
|---|
|
|
|---|
The accuracy of dose prediction methods in predicting initial seizure threshold on an individual patient basis is poor with only 30-50% of the variance being explained by multivariate models and much less with univariate paradigms (Weiner, 1997). The clinical relevance of this inherent inaccuracy is dependent on the distribution of seizure thresholds in the treatment population and the mode of ECT administration. Forty-fold variations in seizure threshold have been reported in research populations, however, the range in clinical groups has been consistently reported as between six- and 12-fold (Weiner, 1997). The range may be misleading as it is likely to reflect sample size and the standard deviation may be a more informative measure. If the spread of seizure thresholds is relatively narrow then dose titration may be unnecessary and a simple dose prediction method would be adequate for most patients. Dose titration could be reserved for situations where there is an increased likelihood of extreme variations in seizure threshold or where the initial response to a predicted dose is poor in terms of antidepressant effect or impaired cognition. Dose titration could be avoided in patients where there is increased anaesthetic risk, particularly if they were thought susceptible to bradyarrythmias.
|
|
References |
|---|
|
|
|---|
BENTHAM, P., CALLINAN, L., RODRIGUEZ-FERERRA, S., et al (1998) Electroconvulsive therapy audit. Journal of Clinical Effectiveness, 3, 72-74.
ENNS, M. & KARVELAS, L. (1995) Electrical dose titration for electroconvulsive therapy: a comparison of dose prediction methods. Convulsive Therapy, 11, 86-93.[Medline]
FARAH, A. & McCALL, W. V. (1993) Electroconvulsive therapy stimulus dosing: a survey of contemporary practices. Convulsive Therapy, 9, 90-94.[Medline]
PETRIDES, G. & FINK, M. (1996) The half-age stimulation strategy for ECT dosing. Convulsive Therapy, 12, 138-146.[Medline]
PIPPARD, J. (1992) Audit of electroconvulsive therapy
in two National Health Service regions. British Journal of
Psychiatry, 160,
621-637.
ROYAL COLLEGE OF PSYCHIATRISTS (1995) The ECT Handbook. The Second Report of The Royal College of Psychiatrists Special Committee on ECT. Council Report CR39. London: Royal College of Psychiatrists.
SACKEIM, H. A., PRUDIC, J., DEVANAND, D. P., et al
(1993) Effects of stimulus intensity and electrode placement on
the efficacy and cognitive effects of electroconvulsive therapy.
New England Journal of Medicine,
328,
839-848.
SWARTZ, C. M. & ABRAMS, R. (1989) ECT Instruction Manual (3rd edn). Lake Bluff, IL: Somatics Inc.
WEINER, R. D. (1997) Stimulus dosing with ECT: to titrate or not to titrate - that is the question. Convulsive Therapy, 13, 7-9.[Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| British Journal of Psychiatry | Advances in Psychiatric Treatment | All RCPsych Journals |